Clinical data shows that approximately 5% of tirzepatide users and a slightly higher percentage of semaglutide users experience noticeable hair loss
Continuous GLP-1RA Use Reduces MACE Risk Incident use of GLP-1RAs was associated with a lower risk of MACE compared to incident use of sulfonylureas
If youre menopausal, experiencing metabolic changes, or simply curious about how to feel better in your body, there are other approaches that may help, including: While Wegovy may not be the right option for you today, we encourage you to speak with a provider about your health goals
Gut health: Support microbiome diversity through probioticrich foods and adequate fiber intake, particularly relevant for inflammatory bowel conditions
Regular monitoring and appropriate dose selection manages these concerns
In the present study, we investigated whether activation of GLP-1R prevented allodynia and inhibited microglial morphological changes and inflammation in the TNC using a chronic nitroglycerin (NTG) injection-stimulated mouse model and the selective GLP-1R agonist liraglutide